DK163640C
(da)
*
|
1985-07-30 |
1992-08-17 |
Glaxo Group Ltd |
Apparat til administrering af medikamenter
|
IT1222509B
(it)
*
|
1987-08-17 |
1990-09-05 |
Miat Spa |
Insufflatore per la somministrazione di farmaci sotto forma di polvere predosata in opercoli
|
US4817789A
(en)
*
|
1987-09-23 |
1989-04-04 |
Allergan, Inc. |
Lens container assembly
|
FR2626500B1
(fr)
*
|
1988-01-28 |
1990-04-27 |
Valois Sa |
Poussoir de vaporisateur agence pour operer le melange d'un additif dans l'emission du jet
|
CH678151A5
(en)
*
|
1988-07-13 |
1991-08-15 |
Heinz Hermann Weick |
Self-medication nasal dispenser
|
GB8824804D0
(en)
*
|
1988-10-22 |
1988-11-30 |
Fisons Plc |
Device
|
SE466684B
(sv)
*
|
1989-03-07 |
1992-03-23 |
Draco Ab |
Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
|
US5176132A
(en)
*
|
1989-05-31 |
1993-01-05 |
Fisons Plc |
Medicament inhalation device and formulation
|
US5239991A
(en)
*
|
1989-06-21 |
1993-08-31 |
Fisons Plc |
Disposable powder medicament inhalation device with peel-off cover
|
IT1230313B
(it)
*
|
1989-07-07 |
1991-10-18 |
Somova Spa |
Inalatore per medicamenti in capsule.
|
DE3927170A1
(de)
*
|
1989-08-17 |
1991-02-21 |
Boehringer Ingelheim Kg |
Inhalator
|
US5208226A
(en)
*
|
1989-09-08 |
1993-05-04 |
Glaxo Group Limited |
Medicaments
|
US5270305A
(en)
*
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
DK544589D0
(da)
*
|
1989-11-01 |
1989-11-01 |
Novo Nordisk As |
Manuel betjent apparat til dispensering af en forudbestemt maengde af et pulverformet stof
|
SK280967B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Inhalačný prístroj
|
US6536427B2
(en)
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
TW197380B
(fr)
*
|
1990-03-02 |
1993-01-01 |
Glaxo Group Ltd |
|
GB9012870D0
(en)
*
|
1990-06-08 |
1990-08-01 |
Glaxo Group Ltd |
Device
|
GB9015522D0
(en)
*
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
IT1243344B
(it)
*
|
1990-07-16 |
1994-06-10 |
Promo Pack Sa |
Inalatore plurimonodose per medicamenti in polvere
|
SE9002895D0
(sv)
*
|
1990-09-12 |
1990-09-12 |
Astra Ab |
Inhalation devices for dispensing powders i
|
US5429122A
(en)
*
|
1990-09-26 |
1995-07-04 |
Zanen; Pieter |
Inhaler devices provided with a reservoir for several doses of medium for inhaling, transporting device, whirl chamber
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
NL9002706A
(nl)
*
|
1990-12-10 |
1992-07-01 |
Pharmachemie Bv |
Inrichting ten gebruike bij het inhaleren van in staafvormige capsules verpakte poedervormige stoffen.
|
US5243970A
(en)
*
|
1991-04-15 |
1993-09-14 |
Schering Corporation |
Dosing device for administering metered amounts of powdered medicaments to patients
|
US5492112A
(en)
*
|
1991-05-20 |
1996-02-20 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US6681767B1
(en)
|
1991-07-02 |
2004-01-27 |
Nektar Therapeutics |
Method and device for delivering aerosolized medicaments
|
CA2444415A1
(fr)
*
|
1991-07-02 |
1993-01-21 |
Nektar Therapeutics |
Methode et instrument pour la delivrance de medicaments en aerosol
|
US5337740A
(en)
*
|
1991-08-01 |
1994-08-16 |
New England Pharmaceuticals, Inc. |
Inhalation devices
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
US5287850A
(en)
*
|
1991-08-20 |
1994-02-22 |
Habley Medical Technology Corporation |
Timing and velocity controlled powered pharmaceutical inhaler
|
DE4128295A1
(de)
*
|
1991-08-27 |
1993-03-04 |
Pfeiffer Erich Gmbh & Co Kg |
Austragvorrichtung fuer fliessfaehige medien
|
GB9124468D0
(en)
*
|
1991-11-18 |
1992-01-08 |
Smithkline Beecham Plc |
Novel device
|
DE4211475A1
(de)
*
|
1991-12-14 |
1993-06-17 |
Asta Medica Ag |
Pulverinhalator
|
GB2264237A
(en)
*
|
1992-02-05 |
1993-08-25 |
Robert Edward Newell |
An inhaler
|
GB9203761D0
(en)
*
|
1992-02-21 |
1992-04-08 |
Innovata Biomed Ltd |
Inhaler
|
EP0558879B1
(fr)
*
|
1992-03-04 |
1997-05-14 |
Astra Aktiebolag |
Inhalateur jetable
|
US5301664A
(en)
*
|
1992-03-06 |
1994-04-12 |
Sievers Robert E |
Methods and apparatus for drug delivery using supercritical solutions
|
JPH0633935Y2
(ja)
*
|
1992-03-27 |
1994-09-07 |
サカセ化学工業株式会社 |
グルーピングメディシンプール
|
WO1993024165A1
(fr)
*
|
1992-05-29 |
1993-12-09 |
Ggu Gesellschaft Für Gesundheits- Und Umweltforschung Mbh & Co. Vertriebs Kg |
Dispositif generateur de particules inhalables de substances actives
|
US5394868A
(en)
*
|
1992-06-25 |
1995-03-07 |
Schering Corporation |
Inhalation device for powdered medicaments
|
US5785049A
(en)
*
|
1994-09-21 |
1998-07-28 |
Inhale Therapeutic Systems |
Method and apparatus for dispersion of dry powder medicaments
|
US6509006B1
(en)
|
1992-07-08 |
2003-01-21 |
Inhale Therapeutic Systems, Inc. |
Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
HU216405B
(hu)
*
|
1993-03-03 |
1999-06-28 |
Tenax Corp. |
Hordozóelem por alakú gyógyszerek adagolására szolgáló inhalálókészülékhez
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
US5372128A
(en)
*
|
1993-04-14 |
1994-12-13 |
Habley Medical Technology Corporation |
Fluidizing powder inhaler
|
US5533502A
(en)
*
|
1993-05-28 |
1996-07-09 |
Vortran Medical Technology, Inc. |
Powder inhaler with aerosolization occurring within each individual powder receptacle
|
BE1007408A3
(nl)
*
|
1993-08-13 |
1995-06-06 |
Winters Joep |
Werkwijze en inrichting voor het controleren van het gebruik van een geneesmiddel.
|
US5524613A
(en)
*
|
1993-08-25 |
1996-06-11 |
Habley Medical Technology Corporation |
Controlled multi-pharmaceutical inhaler
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
EP0748213B1
(fr)
*
|
1994-03-07 |
2004-04-14 |
Nektar Therapeutics |
Procede et preparations pour l'administration d'insuline par voie pulmonaire
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
US6102036A
(en)
*
|
1994-04-12 |
2000-08-15 |
Smoke-Stop |
Breath activated inhaler
|
CA2190502A1
(fr)
*
|
1994-05-18 |
1995-11-23 |
Robert M. Platz |
Procedes et compositions pour produire des interferons sous forme de poudre seche
|
US5483954A
(en)
*
|
1994-06-10 |
1996-01-16 |
Mecikalski; Mark B. |
Inhaler and medicated package
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
ES2302332T3
(es)
|
1994-09-21 |
2008-07-01 |
Nektar Therapeutics |
Aparato y metodos para dispersar medicamentos en polvo seco.
|
FR2725626A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Sofab |
Dispositif pour l'inhalation de produits en poudre
|
DE19500764C2
(de)
*
|
1995-01-13 |
2001-09-27 |
Sofotec Gmbh & Co Kg |
Vorrichtung zum Verabreichen von Medikamenten in fester, in einem Luftstrom fein verteilter Form
|
US5676643A
(en)
*
|
1995-02-13 |
1997-10-14 |
The Procter & Gamble Company |
Dispenser for friably releasing dry particulate medicaments
|
US5780014A
(en)
*
|
1995-04-14 |
1998-07-14 |
Inhale Therapeutic Systems |
Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
US5714007A
(en)
*
|
1995-06-06 |
1998-02-03 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
|
US5669973A
(en)
*
|
1995-06-06 |
1997-09-23 |
David Sarnoff Research Center, Inc. |
Apparatus for electrostatically depositing and retaining materials upon a substrate
|
US20040237961A1
(en)
*
|
1995-06-08 |
2004-12-02 |
Snow John Medlin |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
US6672304B1
(en)
|
1995-06-08 |
2004-01-06 |
Innovative Devices, Llc |
Inhalation actuated device for use with metered dose inhalers (MDIs)
|
DE19523516C1
(de)
*
|
1995-06-30 |
1996-10-31 |
Asta Medica Ag |
Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen
|
US5642727A
(en)
*
|
1995-07-25 |
1997-07-01 |
David Sarnoff Research Center, Inc. |
Inhaler apparatus using a tribo-electric charging technique
|
US6209538B1
(en)
*
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
NL1001031C1
(nl)
*
|
1995-08-23 |
1997-02-25 |
Npk Ind Design B V |
Inrichting voor het afgeven van pillen uit een blisterverpakking.
|
US5649554A
(en)
*
|
1995-10-16 |
1997-07-22 |
Philip Morris Incorporated |
Electrical lighter with a rotatable tobacco supply
|
US5827985A
(en)
*
|
1995-12-19 |
1998-10-27 |
Endress + Hauser Gmbh + Co. |
Sensor apparatus for process measurement
|
US5669378A
(en)
*
|
1995-12-21 |
1997-09-23 |
Pera; Ivo |
Inhaling device
|
TR199801265T2
(xx)
|
1996-01-03 |
1998-10-21 |
Glaxo Group Limited |
��e soluma cihaz�.
|
USD381416S
(en)
*
|
1996-02-08 |
1997-07-22 |
Astra Aktiebolag |
Unit dose inhaler
|
US5743251A
(en)
|
1996-05-15 |
1998-04-28 |
Philip Morris Incorporated |
Aerosol and a method and apparatus for generating an aerosol
|
GB9610821D0
(en)
*
|
1996-05-23 |
1996-07-31 |
Glaxo Wellcome Inc |
Metering apparatus
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
GB9616047D0
(en)
|
1996-07-31 |
1996-09-11 |
Glaxo Group Ltd |
Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
|
WO1998029140A1
(fr)
|
1996-12-31 |
1998-07-09 |
Inhale Therapeutic Systems |
Procedes et compositions de sechage par pulverisation de medicaments hydrophobes dans des solutions de solvant organique d'excipients hydrophiles
|
US20030203036A1
(en)
*
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US5794613A
(en)
*
|
1997-01-09 |
1998-08-18 |
Sepracor, Inc. |
Multiple-dose dispenser for dry powder inhalers
|
TW469832U
(en)
*
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6237590B1
(en)
*
|
1997-09-18 |
2001-05-29 |
Delsys Pharmaceutical Corporation |
Dry powder delivery system apparatus
|
USD417731S
(en)
*
|
1997-10-22 |
1999-12-14 |
The Procter & Gamble Company |
Container for nasal spray
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CN1301185A
(zh)
*
|
1997-12-02 |
2001-06-27 |
杜兰药品公司 |
干粉吸入器
|
US6237591B1
(en)
|
1998-11-02 |
2001-05-29 |
Dura Pharmaceuticals, Inc. |
Turbine dry powder inhaler
|
EP1066074A1
(fr)
*
|
1998-03-16 |
2001-01-10 |
Inhale Therapeutic Systems, Inc. |
Administration d'agents actifs sous forme d'aerosol
|
DE19817417A1
(de)
*
|
1998-04-18 |
1999-10-21 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien, insbesondere Pulver
|
US6257233B1
(en)
*
|
1998-06-04 |
2001-07-10 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US6149774A
(en)
*
|
1998-06-10 |
2000-11-21 |
Delsys Pharmaceutical Corporation |
AC waveforms biasing for bead manipulating chucks
|
DE19831525A1
(de)
*
|
1998-07-14 |
2000-01-20 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
KR100522910B1
(ko)
*
|
1998-09-15 |
2005-12-21 |
주식회사 새 한 |
청량감이 우수한 폴리에스테르 가연가공사의 제조방법
|
UA73924C2
(en)
*
|
1998-10-09 |
2005-10-17 |
Nektar Therapeutics |
Device for delivering active agent formulation to lungs of human patient
|
US6234167B1
(en)
|
1998-10-14 |
2001-05-22 |
Chrysalis Technologies, Incorporated |
Aerosol generator and methods of making and using an aerosol generator
|
US6923979B2
(en)
*
|
1999-04-27 |
2005-08-02 |
Microdose Technologies, Inc. |
Method for depositing particles onto a substrate using an alternating electric field
|
JP4540906B2
(ja)
|
1999-06-05 |
2010-09-08 |
イノバータ・バイオメッド・リミテッド |
放出システム
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6606992B1
(en)
|
1999-06-30 |
2003-08-19 |
Nektar Therapeutics |
Systems and methods for aerosolizing pharmaceutical formulations
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
US6730066B1
(en)
*
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9920839D0
(en)
|
1999-09-04 |
1999-11-10 |
Innovata Biomed Ltd |
Inhaler
|
GB9924415D0
(en)
*
|
1999-10-16 |
1999-12-15 |
Glaxo Group Ltd |
Medicament pack
|
WO2001034234A1
(fr)
*
|
1999-11-11 |
2001-05-17 |
Dura Pharmaceuticals, Inc. |
Inhalateur de poudre seche
|
US6810872B1
(en)
|
1999-12-10 |
2004-11-02 |
Unisia Jecs Corporation |
Inhalant medicator
|
US20010029947A1
(en)
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
MY136453A
(en)
*
|
2000-04-27 |
2008-10-31 |
Philip Morris Usa Inc |
"improved method and apparatus for generating an aerosol"
|
US6883516B2
(en)
*
|
2000-04-27 |
2005-04-26 |
Chrysalis Technologies Incorporated |
Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
|
US6948494B1
(en)
*
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
GB0015034D0
(en)
*
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
PE20020066A1
(es)
*
|
2000-06-23 |
2002-02-23 |
Norton Healthcare Ltd |
Deposito de dosis medidas previamente para inhalador de polvo seco accionado por la respiracion
|
US7575761B2
(en)
*
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
EP1172122A1
(fr)
*
|
2000-07-14 |
2002-01-16 |
The Technology Partnership Public Limited Company |
Inhalateur à poudre séche
|
CO5310534A1
(es)
|
2000-08-05 |
2003-08-29 |
Glaxo Group Ltd |
Nuevos derivados de androstano anti-inflamatorios
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
AU2001286518A1
(en)
*
|
2000-08-15 |
2002-02-25 |
University Of Kentucky Research Foundation |
Programmable multi-dose intranasal drug delivery device
|
SE517229C2
(sv)
*
|
2000-09-25 |
2002-05-14 |
Microdrug Ag |
Kontinuerlig inhalator för torrt pulver
|
GB0023654D0
(en)
|
2000-09-27 |
2000-11-08 |
Cambridge Consultants |
Device for administering doses of particulate material
|
US6595210B2
(en)
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
US7077130B2
(en)
*
|
2000-12-22 |
2006-07-18 |
Chrysalis Technologies Incorporated |
Disposable inhaler system
|
US6681998B2
(en)
|
2000-12-22 |
2004-01-27 |
Chrysalis Technologies Incorporated |
Aerosol generator having inductive heater and method of use thereof
|
US6501052B2
(en)
|
2000-12-22 |
2002-12-31 |
Chrysalis Technologies Incorporated |
Aerosol generator having multiple heating zones and methods of use thereof
|
US6701921B2
(en)
|
2000-12-22 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater in multilayered composite and method of use thereof
|
US6799572B2
(en)
*
|
2000-12-22 |
2004-10-05 |
Chrysalis Technologies Incorporated |
Disposable aerosol generator system and methods for administering the aerosol
|
US6491233B2
(en)
|
2000-12-22 |
2002-12-10 |
Chrysalis Technologies Incorporated |
Vapor driven aerosol generator and method of use thereof
|
MXPA03007017A
(es)
*
|
2001-02-06 |
2004-09-13 |
Innovata Biomed Ltd |
Medicamentos.
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE60224172T2
(de)
|
2001-03-22 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Formanilid-derivative als beta2-adrenorezeptor-agonisten
|
WO2002092154A1
(fr)
|
2001-04-26 |
2002-11-21 |
New England Pharmaceuticals, Inc. |
Distributeur-doseur destine a des agents liquides et en poudre
|
ES2314052T3
(es)
|
2001-04-30 |
2009-03-16 |
Glaxo Group Limited |
Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
US8061006B2
(en)
*
|
2001-07-26 |
2011-11-22 |
Powderject Research Limited |
Particle cassette, method and kit therefor
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
US6540081B2
(en)
*
|
2001-09-06 |
2003-04-01 |
Ecolab Inc. |
Unit dose blister pack product dispenser
|
CA2458534C
(fr)
|
2001-09-14 |
2011-11-01 |
Glaxo Group Limited |
Derives de phenethanolamine destines au traitement de maladies respiratoires
|
WO2003024396A2
(fr)
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Formulations de medicament en poudre seche
|
WO2003024514A1
(fr)
|
2001-09-19 |
2003-03-27 |
Advent Pharmaceuticals Pty Ltd |
Inhaleur
|
US6568390B2
(en)
|
2001-09-21 |
2003-05-27 |
Chrysalis Technologies Incorporated |
Dual capillary fluid vaporizing device
|
US6640050B2
(en)
|
2001-09-21 |
2003-10-28 |
Chrysalis Technologies Incorporated |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
WO2003041777A1
(fr)
*
|
2001-11-14 |
2003-05-22 |
Nektar Therapeutics |
Dispositif a aerosol comprenant un embout de raccordement ameliore
|
GB0128148D0
(en)
*
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
US6681769B2
(en)
|
2001-12-06 |
2004-01-27 |
Crysalis Technologies Incorporated |
Aerosol generator having a multiple path heater arrangement and method of use thereof
|
US6804458B2
(en)
*
|
2001-12-06 |
2004-10-12 |
Chrysalis Technologies Incorporated |
Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
|
US20030168057A1
(en)
*
|
2001-12-14 |
2003-09-11 |
Inhale Therapeutic Systems, Inc. |
Electronically controllable aerosol delivery
|
US6701922B2
(en)
|
2001-12-20 |
2004-03-09 |
Chrysalis Technologies Incorporated |
Mouthpiece entrainment airflow control for aerosol generators
|
US7458373B2
(en)
|
2002-01-15 |
2008-12-02 |
Philip Morris Usa Inc. |
Aerosol generator for drug formulation
|
US20070062525A1
(en)
*
|
2002-01-25 |
2007-03-22 |
Bonney Stanley G |
Medicament dispenser
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
US20060187750A1
(en)
*
|
2002-03-01 |
2006-08-24 |
Victor Aldrich |
Rotary blending apparatus and system
|
WO2003078448A1
(fr)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation de la methylation de proteines et du phosphate des phosphoproteines
|
CA2479751C
(fr)
|
2002-03-20 |
2008-06-03 |
Trent Poole |
Appareil d'inhalation
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
AU2003225973A1
(en)
*
|
2002-03-26 |
2003-11-11 |
Glaxo Group Limited |
A method for forming a laminate assembly and products formed thereby
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
US7429127B2
(en)
*
|
2002-04-25 |
2008-09-30 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
JP2005523920A
(ja)
|
2002-04-25 |
2005-08-11 |
グラクソ グループ リミテッド |
フェネタノールアミン誘導体
|
GB0216562D0
(en)
*
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
AU2003222642A1
(en)
*
|
2002-05-10 |
2003-11-11 |
Chrysalis Technologies Incorporated |
Aerosol generator for drug formulation and methods of generating aerosol
|
JP2005526261A
(ja)
*
|
2002-05-15 |
2005-09-02 |
グラクソ グループ リミテッド |
医薬包装内の温度および水分プロファイルを測定するための微小電気機械システムおよび方法
|
US7185651B2
(en)
*
|
2002-06-18 |
2007-03-06 |
Nektar Therapeutics |
Flow regulator for aerosol drug delivery and methods
|
EP1707205A2
(fr)
|
2002-07-09 |
2006-10-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Compositions pharmaceutiques contenant un antichlinergique et un inhibiteur du p38 pour le traitement de maladies respiratoires
|
DE10230751A1
(de)
|
2002-07-09 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
JP2005533582A
(ja)
*
|
2002-07-25 |
2005-11-10 |
グラクソ グループ リミテッド |
薬剤ディスペンサ
|
EP1534367A1
(fr)
*
|
2002-07-25 |
2005-06-01 |
Glaxo Group Limited |
Distributeur de medicament
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
CN100482352C
(zh)
*
|
2002-09-06 |
2009-04-29 |
菲利普莫里斯美国公司 |
气溶胶产生装置和方法
|
US20070139442A1
(en)
*
|
2002-09-13 |
2007-06-21 |
Robinson Karl E |
Coated blending system
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
JP2006506373A
(ja)
*
|
2002-10-22 |
2006-02-23 |
グラクソ グループ リミテッド |
医薬アリールエタノールアミン化合物
|
US6772757B2
(en)
|
2002-10-25 |
2004-08-10 |
Chrysalis Technologies Incorporated |
Concentric controlled temperature profile fluid vaporizing device
|
EP1556342B1
(fr)
|
2002-10-28 |
2008-03-26 |
Glaxo Group Limited |
Derive de phenethanolamine utilise dans le traitement de maladies respiratoires
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
US6941947B2
(en)
*
|
2002-12-18 |
2005-09-13 |
Quadrant Technologies Limited |
Unit dose dry powder inhaler
|
WO2004060260A2
(fr)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Systeme d'administration de medicament dote d'un embout buccal a event
|
WO2004066912A2
(fr)
*
|
2003-01-31 |
2004-08-12 |
Technion Research & Development Foundation Ltd. |
Compositions anti-inflammatoires et leurs utilisations
|
CA2515395A1
(fr)
*
|
2003-02-11 |
2004-08-26 |
Boehringer Ingelheim International Gmbh |
Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de proteines hybrides solubles du recepteur du facteur de necrose des tumeurs
|
JP2006517214A
(ja)
*
|
2003-02-11 |
2006-07-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規な抗コリン作用剤とTNFα合成又は作用阻害剤に基づく新規な医薬組成物
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
US20040245279A1
(en)
*
|
2003-05-05 |
2004-12-09 |
Bradley Tareasa L. |
System for dispensing an active ingredient using a dispensable tablet, dispensable tablet and container for holding such dispensable tablets
|
TW200510298A
(en)
|
2003-06-13 |
2005-03-16 |
Theravance Inc |
Substituted pyrrolidine and related compounds
|
EP1488819A1
(fr)
*
|
2003-06-16 |
2004-12-22 |
Rijksuniversiteit te Groningen |
Inhalateur de poudre sèche et procédé d'inhalation pulmonaire de poudre sèche
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
PE20050250A1
(es)
|
2003-07-17 |
2005-04-08 |
Glaxo Group Ltd |
Antagonistas de los receptores muscarinicos de la acetilcolina
|
GB0317374D0
(en)
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
RU2375059C2
(ru)
|
2003-07-29 |
2009-12-10 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Ингаляционные лекарственные средства, содержащие бета-миметики и антихолинергическое средство
|
US7367334B2
(en)
|
2003-08-27 |
2008-05-06 |
Philip Morris Usa Inc. |
Fluid vaporizing device having controlled temperature profile heater/capillary tube
|
US6991131B2
(en)
*
|
2003-09-02 |
2006-01-31 |
Ecolab, Inc. |
Distributable container and system and method using distributable container
|
AU2004273547B2
(en)
*
|
2003-09-24 |
2006-07-06 |
Tianda Pharmaceuticals (Australia) Pty Ltd |
Medication holder
|
JP4445966B2
(ja)
|
2003-09-24 |
2010-04-07 |
メディ−ストリーム プロプライエタリィ リミティッド |
薬物ホルダー
|
DE602004030930D1
(de)
|
2003-10-14 |
2011-02-17 |
Glaxo Group Ltd |
Muscarinische acetylcholin-rezeptor-antagonisten
|
GB2407042B
(en)
*
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
US7507747B2
(en)
|
2003-10-17 |
2009-03-24 |
Glaxo Group Limited |
Muscarinic acetylcholine receptor antagonists
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
WO2005044173A1
(fr)
*
|
2003-10-27 |
2005-05-19 |
Oriel Therapeutics, Inc. |
Emballages-coque et procedes associes de fabrication de systemes de confinement de medicaments en poudre seche
|
JP2007509941A
(ja)
*
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
GB0325627D0
(en)
*
|
2003-11-03 |
2003-12-10 |
Glaxo Group Ltd |
A hand-held capsule device
|
RS51758B
(en)
|
2003-11-03 |
2011-12-31 |
Boehringer Ingelheim International Gmbh. |
PROCEDURE FOR OBTAINING SALT TIOTROPIUM
|
ATE478071T1
(de)
|
2003-11-03 |
2010-09-15 |
Boehringer Ingelheim Int |
Verfahren zur herstellung neuer tiotropiumsalze
|
PE20050489A1
(es)
|
2003-11-04 |
2005-09-02 |
Glaxo Group Ltd |
Antagonistas de receptores de acetilcolina muscarinicos
|
GB0329182D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US8147426B2
(en)
*
|
2003-12-31 |
2012-04-03 |
Nipro Diagnostics, Inc. |
Integrated diagnostic test system
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
US7384946B2
(en)
|
2004-03-17 |
2008-06-10 |
Glaxo Group Limited |
M3 muscarinic acetylcholine receptor antagonists
|
US7846973B2
(en)
|
2004-04-02 |
2010-12-07 |
Theravance, Inc. |
Chemical process and new crystalline form
|
BRPI0509348A
(pt)
*
|
2004-04-21 |
2007-09-11 |
Innovata Biomed Ltd |
inalador
|
US20050272726A1
(en)
*
|
2004-04-22 |
2005-12-08 |
Boehringer Ingelheim International Gmbh |
Novel medicaments for the treatment of respiratory diseases
|
ES2380370T3
(es)
|
2004-04-22 |
2012-05-11 |
Boehringer Ingelheim International Gmbh |
Combinaciones farmacológicas que contienen benzoxazina para el tratamiento de enfermedades de las vías respiratorias
|
US7861712B2
(en)
|
2004-04-23 |
2011-01-04 |
Manta Product Development |
Sealed capsule including an integrated puncturing mechanism
|
GB0409197D0
(en)
|
2004-04-24 |
2004-05-26 |
Innovata Biomed Ltd |
Device
|
AR050902A1
(es)
|
2004-04-27 |
2006-12-06 |
Glaxo Group Ltd |
Compuesto de quinuclidina, composicion farmaceutica que lo comprende y su usopara preparar dicha composicion
|
US7727962B2
(en)
*
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7611709B2
(en)
*
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7723306B2
(en)
*
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
JP2007537261A
(ja)
|
2004-05-13 |
2007-12-20 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
US20050256115A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Aerosol formulation for the inhalation of beta-agonists
|
WO2005110519A1
(fr)
*
|
2004-05-17 |
2005-11-24 |
Sun Pharmaceutical Industries Limited |
Inhalateur a poudre seche
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
US7896195B2
(en)
*
|
2004-06-08 |
2011-03-01 |
Ecolab Inc. |
Tablet dispenser with isolated product hopper
|
WO2006009776A2
(fr)
*
|
2004-06-17 |
2006-01-26 |
Signal Investment & Management Co. |
Dispositif de support reutilisable muni d'inserts therapeutiques
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
US20060079544A1
(en)
*
|
2004-08-13 |
2006-04-13 |
Boehringer Ingelheim International Gmbh |
Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
|
GB0418278D0
(en)
*
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
KR101273120B1
(ko)
|
2004-08-20 |
2013-06-13 |
맨카인드 코포레이션 |
다이케토피페라진 합성의 촉매 작용
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
GB0418738D0
(en)
*
|
2004-08-23 |
2004-09-22 |
3M Innovative Properties Co |
Medicinal aerosol formulation receptacle and production thereof
|
WO2006047663A2
(fr)
*
|
2004-10-26 |
2006-05-04 |
The University Of North Carolina At Chapel Hill |
Filament enduit pour production d'aerosols par evaporation/condensation d'agents therapeutiques et methodes d'utilisation
|
JP2006130143A
(ja)
*
|
2004-11-08 |
2006-05-25 |
Hitachi Ltd |
吸入式投薬器及び薬剤カートリッジ
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
JP2008519984A
(ja)
*
|
2004-11-12 |
2008-06-12 |
グラクソ グループ リミテッド |
音響変換器を備えるセンサシステム
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
DK2377557T3
(en)
|
2004-11-24 |
2017-02-06 |
Meda Pharmaceuticals Inc |
Compositions comprising azelastine and methods for its use
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
JP2008526805A
(ja)
*
|
2005-01-11 |
2008-07-24 |
グラクソ グループ リミテッド |
ベータ−2アドレナリン作動薬のケイヒ酸塩
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US8221804B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
EP1858528A2
(fr)
*
|
2005-02-10 |
2007-11-28 |
Glaxo Group Limited |
Procede de cristallisation de particules de lactose en vue d'une utilisation dans des preparations pharmaceutiques
|
RU2007133547A
(ru)
|
2005-02-10 |
2009-03-20 |
Глаксо Груп Лимитед (GB) |
Способы получения лактозы с использованием методов предварительной сортировки и приготовляемые из нее фармацевтические композиции
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
TW200724142A
(en)
|
2005-03-25 |
2007-07-01 |
Glaxo Group Ltd |
Novel compounds
|
GB0507711D0
(en)
|
2005-04-15 |
2005-05-25 |
Vectura Group Plc |
Improved blister piercing
|
WO2007052154A2
(fr)
|
2005-04-29 |
2007-05-10 |
University Of Medicine And Dentistry Of New Jersey |
Peptide court derive d'erythropoietine et ses mimetiques utilises comme modulateurs immuno / inflammatoires
|
US9585932B2
(en)
|
2005-04-29 |
2017-03-07 |
Peter C. Dowling |
Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
|
US9345745B2
(en)
*
|
2005-04-29 |
2016-05-24 |
Bo Wang |
Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides
|
DK1881980T3
(da)
|
2005-05-02 |
2012-10-01 |
Boehringer Ingelheim Int |
Nye krystalline former af tiotropiumbromid
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
PT1901749T
(pt)
|
2005-05-18 |
2016-11-04 |
Raptor Pharmaceuticals Inc |
Fluoroquinolonas aerossolizadas e suas utilizações
|
JP2008543806A
(ja)
*
|
2005-06-17 |
2008-12-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器疾患の治療のためのmrpivインヒビター
|
DE102005030733A1
(de)
|
2005-07-01 |
2007-01-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US20070012316A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Joann Truza |
Disposable compact rescue inhaler
|
US8763605B2
(en)
|
2005-07-20 |
2014-07-01 |
Manta Devices, Llc |
Inhalation device
|
GB0515584D0
(en)
*
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
CN101208316B
(zh)
|
2005-08-15 |
2012-05-09 |
贝林格尔·英格海姆国际有限公司 |
制备β-模拟物的方法
|
WO2007022351A2
(fr)
|
2005-08-18 |
2007-02-22 |
Glaxo Group Limited |
Antagonistes de recepteurs d'acetylcholine muscarinique
|
CA2620123C
(fr)
*
|
2005-08-24 |
2011-11-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
|
US20090192227A1
(en)
*
|
2005-08-24 |
2009-07-30 |
Rabindra Tirouvanziam |
N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
|
US20130131007A1
(en)
|
2005-09-07 |
2013-05-23 |
Bebaas, Inc. |
Vitamin b12 compositions
|
US8642543B2
(en)
*
|
2005-09-07 |
2014-02-04 |
Neurotez, Inc. |
Methods for treating progressive cognitive disorders related to neurofibrillary tangles
|
US8227408B2
(en)
*
|
2005-09-07 |
2012-07-24 |
Neurotez, Inc. |
Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
|
US20070178141A1
(en)
*
|
2005-09-07 |
2007-08-02 |
Bebaas, Inc. |
Vitamin B12 compositions
|
US7481331B2
(en)
*
|
2005-09-09 |
2009-01-27 |
Manrex Limited |
Dispensing container for a blister pack of medications
|
KR101486397B1
(ko)
|
2005-09-14 |
2015-01-28 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US20070086957A1
(en)
|
2005-10-10 |
2007-04-19 |
Thierry Bouyssou |
Combination of medicaments for the treatment of respiratory diseases
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
DE102005057685A1
(de)
*
|
2005-12-01 |
2007-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
AR058289A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
DE102005059602A1
(de)
|
2005-12-14 |
2007-06-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Mikronisierung
|
BRPI0707991B8
(pt)
|
2006-02-22 |
2021-05-25 |
Mannkind Corp |
métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
|
WO2007103152A2
(fr)
*
|
2006-03-03 |
2007-09-13 |
Stc.Unm |
Inhalateur a poudre seche avec mecanisme de dispersion aeroelastique
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
DE102006016904A1
(de)
*
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
EP1844808A1
(fr)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Dispositif pour délivrer un médicament
|
EP1844805A1
(fr)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Inhalateur
|
PT103481B
(pt)
|
2006-05-16 |
2008-08-01 |
Hovione Farmaciencia S A |
Inalador de uso simples e método de inalação
|
EP2361955B1
(fr)
|
2006-05-19 |
2014-12-17 |
Valspar Sourcing, Inc. |
Système de revêtement pour articles à composites de ciment
|
EP2043717A1
(fr)
*
|
2006-07-14 |
2009-04-08 |
Astra Zeneca AB |
Systeme d'inhalation et dispositif de distribution pour l'administration de medicament sous forme d'une poudre seche
|
ATE505193T1
(de)
|
2006-08-07 |
2011-04-15 |
Boehringer Ingelheim Int |
Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
|
UY30552A1
(es)
*
|
2006-08-22 |
2008-03-31 |
Boehringer Ingelheim Int |
Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
|
DE102006045788A1
(de)
*
|
2006-09-26 |
2008-03-27 |
Alfred Von Schuckmann |
Spender für pulverförmige Massen
|
KR101501784B1
(ko)
|
2006-10-25 |
2015-03-11 |
노파르티스 아게 |
분말 분산 장치, 이 장치를 제작 및 사용하는 방법, 및 장치 및 기타 기기 상에서 사용될 수 있는 구성요소
|
GB0622827D0
(en)
*
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(fr)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Formule de poudre stable contenant un nouveau anticholinergique
|
CA2689296C
(fr)
|
2007-01-10 |
2015-11-17 |
Purdue Research Foundation |
Inhibiteurs polypeptidiques de la hsp27 kinase et leurs utilisations
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
US20080237082A1
(en)
*
|
2007-03-29 |
2008-10-02 |
R. P. Scherer Technologies, Inc. |
Child resistant device for housing blister packs
|
AT505246B8
(de)
*
|
2007-06-01 |
2009-06-15 |
Croma Pharma Gmbh |
Container für eine mehrzahl von einzeldosen sowie applikator für derartige container
|
US11224704B2
(en)
|
2007-07-06 |
2022-01-18 |
Manta Devices, Llc |
Dose delivery device for inhalation
|
DK2898914T3
(en)
|
2007-07-06 |
2018-09-03 |
Manta Devices Llc |
INHALATION DEVICES FOR STORAGE AND DELIVERY OF MEDICINES
|
DK2185698T3
(en)
|
2007-08-07 |
2015-07-27 |
Purdue Research Foundation |
Kinase Inhibitors and Uses thereof
|
EP2093219A1
(fr)
|
2008-02-22 |
2009-08-26 |
Boehringer Ingelheim International Gmbh |
Forme de sel à énantiomère pur et cristalline d'un bêtamimétique et son utilisation comme médicament
|
EP2268160B1
(fr)
|
2008-03-20 |
2012-12-05 |
Virun, Inc. |
Émulsions comprenant un dérivé de peg de tocophérol
|
CA2715018C
(fr)
|
2008-03-20 |
2012-11-13 |
Virun, Inc. |
Derives de la vitamine e et leurs utilisations
|
CN104491962B
(zh)
*
|
2008-06-13 |
2018-10-23 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
ES2421385T3
(es)
|
2008-06-20 |
2013-09-02 |
Mannkind Corp |
Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación
|
US8337931B2
(en)
*
|
2008-06-23 |
2012-12-25 |
Virun, Inc. |
Compositions containing non-polar compounds
|
JP5339794B2
(ja)
*
|
2008-07-04 |
2013-11-13 |
キヤノン株式会社 |
吸入装置
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
AU2009296538B8
(en)
|
2008-09-26 |
2013-06-27 |
Oriel Therapeutics, Inc. |
Inhalers with airway disks having discrete airway channels and related disks and methods
|
MX2011003232A
(es)
*
|
2008-09-26 |
2011-04-21 |
Oriel Therapeutics Inc |
Mecanismos inhaladaores con perforadores radialmente desviados y métodos relacionados.
|
KR101650075B1
(ko)
|
2008-09-26 |
2016-08-22 |
오리엘 테라퓨틱스, 인크. |
이중 관통 부재들을 구비한 건조 분말 흡입기, 및 그와 관련된 장치 및 방법
|
WO2010039201A2
(fr)
*
|
2008-09-30 |
2010-04-08 |
Oriel Therapeutics, Inc. |
Inhalateurs de poudre sèche comportant un compartiment de désagglomération à surface multifacettes, et dispositifs et procédés associés
|
CA2732827C
(fr)
*
|
2008-10-01 |
2016-10-11 |
Oriel Therapeutics, Inc. |
Inhalateurs de poudre seche a mecanismes de percement rotatifs, et dispositifs et procedes associes
|
PL2344129T3
(pl)
|
2008-10-07 |
2018-07-31 |
Horizon Orphan Llc |
Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
|
EP2346509B1
(fr)
*
|
2008-10-07 |
2020-05-13 |
Horizon Orphan LLC |
Inhalation de lévofloxacine pour réduire une inflammation des poumons
|
CA2741302C
(fr)
*
|
2008-10-20 |
2017-02-28 |
Moerae Matrix, Inc. |
Polypeptide inhibiteur de la kinase mapkap destine au traitement ou a la prevention des adherences
|
CA2742600A1
(fr)
*
|
2008-11-04 |
2010-05-14 |
Nikolaos Tezapsidis |
Compositions a base de leptine et methodes de traitement de troubles evolutifs de la fonction cognitive provoques par une accumulation d'enchevetrements neurofibrillaires et de beta-amyloide
|
KR101965255B1
(ko)
*
|
2008-12-10 |
2019-04-03 |
퍼듀 리서치 파운데이션 |
키나아제의 세포-침투성 펩티드-기초된 저해물질
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
WO2010083042A1
(fr)
|
2009-01-15 |
2010-07-22 |
Manta Devices, Llc |
Dispositif d'administration
|
GB0901520D0
(en)
*
|
2009-01-30 |
2009-03-11 |
Vectura Delivery Devices Ltd |
Inhaler
|
EP3620154A1
(fr)
*
|
2009-02-06 |
2020-03-11 |
University Of Southern California |
Compositions thérapeutiques comprenant des monoterpènes
|
JP2012517405A
(ja)
|
2009-02-09 |
2012-08-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器及び胃腸の疾患の治療のための新規医薬組成物
|
PL2400950T3
(pl)
|
2009-02-26 |
2019-12-31 |
Glaxo Group Limited |
Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
|
CA2754595C
(fr)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Appareil, systeme et procede de mesure de resistance d'un inhalateur
|
EP2405747A4
(fr)
*
|
2009-03-13 |
2013-01-16 |
Nucitec Sa De Cv |
Compositions et méthodes de traitement et prévention de maladies cardiovasculaires
|
CN102355918B
(zh)
|
2009-03-18 |
2014-07-16 |
曼金德公司 |
用于激光衍射设备的吸入器适配器和用于测量颗粒尺寸分布的方法
|
US8734845B2
(en)
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
CN102834406A
(zh)
|
2009-06-16 |
2012-12-19 |
默沙东公司 |
作为糖皮质激素受体激动剂的新的[3.2-c]杂芳基甾体、其组合物和用途
|
EP2451787B1
(fr)
|
2009-07-06 |
2013-04-24 |
Boehringer Ingelheim International GmbH |
Polymorphe de [4,6-bis(diméthylamino)-2-(4-{[4-(trifluorométhyl)benzoyl]amino}benzyl)pyrimidin-5-yl]acétique
|
BR112012000890A2
(pt)
|
2009-07-15 |
2017-10-31 |
Theravance Inc |
formas de base livre cristalina de um composto bifenil
|
EP3202399A1
(fr)
|
2009-07-24 |
2017-08-09 |
Amazetis SA |
Composés, compositions et procédés de protection de la santé cérébrale dans les troubles neurodégénératifs
|
WO2011017132A2
(fr)
*
|
2009-07-27 |
2011-02-10 |
Purdue Research, Foundation |
Compositions d'inhibiteurs de mk2 et procédés d'amélioration de l'excroissance des neurites, de la neuroprotection et de la régénération des nerfs
|
AU2010289326B2
(en)
|
2009-09-04 |
2015-09-24 |
Horizon Therapeutics U.S. Holding Llc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
CN102573886A
(zh)
*
|
2009-09-17 |
2012-07-11 |
相互制药公司 |
用抗病毒剂治疗哮喘的方法
|
US9016147B2
(en)
|
2009-11-03 |
2015-04-28 |
Mannkind Corporation |
Apparatus and method for simulating inhalation efforts
|
EP2498848A2
(fr)
|
2009-11-12 |
2012-09-19 |
Stc.Unm |
Inhalateur pour poudre sèche avec un élément de dispersion par flottement
|
EP2504318A2
(fr)
|
2009-11-24 |
2012-10-03 |
Boehringer Ingelheim International GmbH |
Nouvelles formes salines d'un dérivé de l'acide pyrimidin-5-yl acétique
|
BR112012012384A2
(pt)
|
2009-11-24 |
2016-03-22 |
Boehringer Ingelheim Int |
processo para preparar um polímero do sal de colina de [4,6-bi(dimetilamino--2-(4-{[4-(trifluorometil)-benzoil]amino}benzil)pirimidin-5-il}
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
US10210216B2
(en)
*
|
2009-12-18 |
2019-02-19 |
Sybase, Inc. |
Dynamic attributes for mobile business objects
|
US8507734B2
(en)
|
2010-03-03 |
2013-08-13 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising monoterpenes
|
WO2011116293A2
(fr)
|
2010-03-19 |
2011-09-22 |
Manta Devices, Llc |
Dispositif d'administration et procédés apparentés
|
CA2792330C
(fr)
|
2010-03-23 |
2017-01-03 |
Virun, Inc |
Nanoemulsion comportant un derive peg de vitamine e et un sucrose ester d'acide gras
|
USD641076S1
(en)
|
2010-03-26 |
2011-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhaler
|
USD635246S1
(en)
|
2010-03-26 |
2011-03-29 |
Oriel Therapeutics, Inc. |
Dose disk for dry powder inhalers
|
EP2582421A1
(fr)
|
2010-06-21 |
2013-04-24 |
MannKind Corporation |
Système et procédé d'administration de médicament sous la forme d'une poudre sèche
|
US8741373B2
(en)
|
2010-06-21 |
2014-06-03 |
Virun, Inc. |
Compositions containing non-polar compounds
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
EP2898883B1
(fr)
|
2010-08-27 |
2016-11-23 |
Neonc Technologies Inc. |
Compositions pharmaceutiques comprenant des carbamates d'alcool périllylique
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
JP5792307B2
(ja)
|
2010-08-31 |
2015-10-07 |
グラクソ グループ リミテッドGlaxo Group Limited |
水分制御特性を示す乾燥粉末吸入薬物製品及びその投与方法
|
SG190793A1
(en)
|
2010-11-11 |
2013-07-31 |
Agency Science Tech & Res |
Targeting metabolic enzymes in human cancer
|
ES2646748T3
(es)
|
2010-12-07 |
2017-12-15 |
Respira Therapeutics, Inc. |
Inhalador de polvo seco
|
EP4374929A3
(fr)
|
2010-12-17 |
2024-08-07 |
University of Southern California |
Procédés et dispositifs d'utilisation d'alcool isoperillylique
|
WO2012106382A1
(fr)
|
2011-01-31 |
2012-08-09 |
Genoa Pharmaceuticals, Inc. |
Composés analogues de pyridone et de pirfénidone en aérosol, et leurs utilisations
|
SG10201606220QA
(en)
|
2011-04-01 |
2016-09-29 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
DK2696888T3
(en)
|
2011-04-12 |
2019-03-25 |
Moerae Matrix Inc |
COMPOSITIONS AND METHODS FOR PREVENTION OR TREATMENT OF PULMONAL FIBROSE
|
CA2836643C
(fr)
|
2011-05-19 |
2017-11-14 |
Savara, Inc. |
Compositions de poudre seche de vancomycine et methodes associees
|
WO2012174472A1
(fr)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
Microparticules de dicétopipérazine de capacité élevée
|
US8528569B1
(en)
|
2011-06-28 |
2013-09-10 |
Kyle D. Newton |
Electronic cigarette with liquid reservoir
|
US11103659B2
(en)
|
2011-07-06 |
2021-08-31 |
Manta Devices, Llc |
Delivery device and related methods
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
KR20140095483A
(ko)
|
2011-10-24 |
2014-08-01 |
맨카인드 코포레이션 |
통증을 치료하기 위한 방법 및 조성물
|
EP2589381B1
(fr)
|
2011-11-04 |
2016-08-31 |
Rabindra Tirouvanziam |
Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
|
EP2809780B1
(fr)
|
2012-02-01 |
2018-05-02 |
Protalix Ltd. |
Composition liquide inhalable de dnase i
|
SG11201404640YA
(en)
|
2012-02-10 |
2014-09-26 |
Virun Inc |
Beverage compositions containing non-polar compounds
|
US10525216B2
(en)
|
2012-02-21 |
2020-01-07 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
US9452218B2
(en)
|
2012-03-09 |
2016-09-27 |
Purdue Research Foundation |
Compositions and methods for delivery of kinase inhibiting peptides
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
KR20150013463A
(ko)
|
2012-04-27 |
2015-02-05 |
글락소 그룹 리미티드 |
신규 화합물
|
US9649454B2
(en)
|
2012-05-03 |
2017-05-16 |
Manta Devices, Llc |
Delivery device and related methods
|
WO2013176638A1
(fr)
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhalateur comportant une embouchure ayant un canal d'air amélioré
|
JP6312262B2
(ja)
|
2012-07-12 |
2018-04-18 |
マンカインド コーポレイション |
乾燥粉末薬物送達システム
|
CN115414384A
(zh)
|
2012-09-04 |
2022-12-02 |
埃莱森制药有限责任公司 |
用顺铂脂质复合物预防癌症的肺部复发
|
WO2014066856A1
(fr)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Compositions et procédés de vaccin antigrippal inhalable
|
WO2014085474A1
(fr)
|
2012-11-28 |
2014-06-05 |
Intercept Pharmaceuticals, Inc. |
Traitement d'une maladie pulmonaire
|
GB201301192D0
(en)
|
2013-01-23 |
2013-03-06 |
Vectura Delivery Devices Ltd |
A blister piercing element for a dry powder inhaler
|
SG11201507564PA
(en)
|
2013-03-15 |
2015-10-29 |
Mannkind Corp |
Microcrystalline diketopiperazine compositions and methods
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
DK177788B1
(en)
|
2013-07-12 |
2014-07-07 |
Liita Holdings Ltd |
Inhaler
|
AU2014290438B2
(en)
|
2013-07-18 |
2019-11-07 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
US20150044288A1
(en)
|
2013-07-31 |
2015-02-12 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
AU2014318821B2
(en)
|
2013-09-10 |
2018-04-19 |
Board Of Regents Of The University Of Texas System |
Therapeutics targeting truncated Adenomatous Polyposis Coli (APC) proteins
|
US10039321B2
(en)
|
2013-11-12 |
2018-08-07 |
Vmr Products Llc |
Vaporizer
|
US10058129B2
(en)
|
2013-12-23 |
2018-08-28 |
Juul Labs, Inc. |
Vaporization device systems and methods
|
CA3155455A1
(en)
|
2013-12-23 |
2015-07-02 |
Juul Labs, Inc. |
Vaporization device systems and methods
|
US10076139B2
(en)
|
2013-12-23 |
2018-09-18 |
Juul Labs, Inc. |
Vaporizer apparatus
|
USD769438S1
(en)
*
|
2014-01-08 |
2016-10-18 |
Glaxo Group Limited |
Inhaler device
|
WO2015106150A1
(fr)
|
2014-01-10 |
2015-07-16 |
Genoa Pharmaceuticals Inc. |
Composés analogues de pyridone et de pirfénidone en aérosol, et leurs utilisations
|
US10709173B2
(en)
|
2014-02-06 |
2020-07-14 |
Juul Labs, Inc. |
Vaporizer apparatus
|
TWI828016B
(zh)
|
2014-02-06 |
2024-01-01 |
美商尤爾實驗室有限公司 |
用於產生可吸入蒸汽之電子裝置及包括該電子裝置之系統及套件
|
WO2015148905A1
(fr)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Utilisation d'insuline à action ultrarapide
|
US10336788B2
(en)
|
2014-04-17 |
2019-07-02 |
Moerae Matrix, Inc. |
Inhibition of cardiac fibrosis in myocardial infarction
|
WO2015164142A1
(fr)
*
|
2014-04-24 |
2015-10-29 |
Questa Corporation |
Coupe-pilule multidimensionnel et méthodes associées
|
US11147936B2
(en)
*
|
2014-05-02 |
2021-10-19 |
Manta Devices, Llc |
Dose delivery device with cover connected to dose chamber seal
|
CA2948441A1
(fr)
|
2014-05-12 |
2015-11-19 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Compositions pharmaceutiques pour traiter des maladies infecteuses
|
US10940279B2
(en)
*
|
2014-07-01 |
2021-03-09 |
Jennifer K. Keener |
Aromatherapy device
|
US10082496B2
(en)
|
2014-09-10 |
2018-09-25 |
Board Of Regents Of The University Of Texas System |
Targeting emopamil binding protein (EBP) with small molecules that induce an abnormal feedback response by lowering endogenous cholesterol biosynthesis
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
WO2016057693A1
(fr)
|
2014-10-10 |
2016-04-14 |
Alnylam Pharmaceuticals, Inc. |
Procédés et compositions pour administration par inhalation d'oligonucléotide conjugué
|
WO2016067252A1
(fr)
|
2014-10-31 |
2016-05-06 |
Glaxosmithkline Intellectual Property Development Limited |
Formulation de poudre
|
JP2018501201A
(ja)
|
2014-11-17 |
2018-01-18 |
モイライ マトリックス インコーポレイテッド |
異常な線維芽細胞増殖および細胞外マトリックス沈着を特徴とする疾患、状態、またはプロセスを予防または処置するための組成物および方法
|
CA2970140A1
(fr)
|
2014-12-10 |
2016-06-16 |
Hyperstem, SA |
Procedes et compositions de reduction de la croissance, de la migration et du caractere invasif des cellules souches du cancer du cerveau, et d'amelioration de la survie de patients atteints de tumeurs du cerveau
|
SG11201705559RA
(en)
|
2015-01-08 |
2017-08-30 |
Moerae Matrix Inc |
Formulation of mk2 inhibitor peptides
|
US9522918B2
(en)
|
2015-02-12 |
2016-12-20 |
Neonc Technologies, Inc. |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
EP3061501A1
(fr)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition pour le traitement de l'acné
|
BR112017019412A2
(pt)
|
2015-03-11 |
2018-05-02 |
Glaxosmithkline Ip Dev Ltd |
proteínas ligadoras de tslp
|
US9999655B2
(en)
|
2015-03-12 |
2018-06-19 |
Moerae Matrix, Inc. |
Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
|
US10179215B2
(en)
|
2015-03-19 |
2019-01-15 |
Altria Client Services Llc |
Vaporizer for vaporizing a constituent of a plant material
|
AU2016201131B2
(en)
*
|
2015-03-30 |
2020-04-02 |
Manrex Limited |
Dispensing container for blister pack of medication
|
US9937154B2
(en)
|
2015-06-10 |
2018-04-10 |
Hackensak University Medical Center |
Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
|
EP3307719A1
(fr)
|
2015-06-15 |
2018-04-18 |
GlaxoSmithKline Intellectual Property Development Limited |
Régulateurs de nrf2
|
PT3307739T
(pt)
|
2015-06-15 |
2021-01-04 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de nrf2
|
AU2016280236B2
(en)
|
2015-06-15 |
2019-02-07 |
Astex Therapeutics Limited |
Nrf2 regulators
|
WO2017007634A1
(fr)
|
2015-07-06 |
2017-01-12 |
The Board Of Regents Of The University Of Texas System |
Composés benzamide ou benzamine à utiliser en tant qu'anticancéreux pour le traitement de cancers humains
|
EP3322417B1
(fr)
|
2015-07-15 |
2023-08-23 |
The Board of Regents of The University of Texas System |
Ciblage de protéine de liaison de l'emopamil (ebp) avec de petites molécules qui induisent une réponse de rétroaction anormale par l'abaissement de la biosynthèse du cholestérol endogène
|
EP3117825A1
(fr)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Formulation orale comprenant de la berbérine et un extrait de morus alba
|
CN105013054B
(zh)
*
|
2015-07-30 |
2018-11-09 |
中山市美捷时包装制品有限公司 |
一种多胶囊型干粉吸入装置
|
CN104984448B
(zh)
*
|
2015-07-30 |
2018-05-01 |
中山市美捷时包装制品有限公司 |
一种干粉吸入器
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
US10351530B2
(en)
|
2015-10-06 |
2019-07-16 |
Glaxosmithkline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as NRF2 regulators
|
EP3359532A1
(fr)
|
2015-10-06 |
2018-08-15 |
GlaxoSmithKline Intellectual Property Development Limited |
Biaryl pyrazoles utilisés comme régulateurs de nrf2
|
JP2018535984A
(ja)
|
2015-11-18 |
2018-12-06 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
リバビリンの医薬組成物
|
WO2017127641A1
(fr)
|
2016-01-20 |
2017-07-27 |
Flurry Powders |
Encapsulation d'ingrédients lipophiles dans des poudres séchées par pulvérisation pouvant être dispersées destinées à l'inhalation
|
US11833118B2
(en)
|
2016-01-20 |
2023-12-05 |
Flurry Powders, Llc |
Encapsulation of lipophilic ingredients in dispersible spray dried powders suitable for inhalation
|
USD861975S1
(en)
|
2016-02-08 |
2019-10-01 |
Juul Labs, Inc. |
Vaporizer device with cartridges
|
EP3413960B1
(fr)
|
2016-02-11 |
2021-03-31 |
Juul Labs, Inc. |
Cartouche de vaporisateur remplissable et procédé de remplissage
|
SG10202108578XA
(en)
|
2016-02-11 |
2021-09-29 |
Juul Labs Inc |
Securely attaching cartridges for vaporizer devices
|
US11224705B2
(en)
|
2016-02-24 |
2022-01-18 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
US10912333B2
(en)
|
2016-02-25 |
2021-02-09 |
Juul Labs, Inc. |
Vaporization device control systems and methods
|
JP2019532054A
(ja)
|
2016-09-20 |
2019-11-07 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
Trpv4拮抗薬
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
CN109790116B
(zh)
|
2016-09-20 |
2022-10-28 |
葛兰素史密斯克莱知识产权(第2 号)有限公司 |
Trpv4拮抗剂
|
US10858305B2
(en)
|
2016-11-30 |
2020-12-08 |
Neonc Technologies, Inc. |
Perillyl alcohol-3-bromopyruvate conjugate and methods of treating cancer
|
KR20190088404A
(ko)
|
2016-12-06 |
2019-07-26 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
|
US10426698B2
(en)
*
|
2016-12-08 |
2019-10-01 |
Breeden Brothers, LLC |
Pill container with cap
|
JP2020500919A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしての3−カルボン酸ピロール
|
WO2018109642A1
(fr)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles en tant que régulateurs de nrf2
|
JP2020502136A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしてのビスアリールアミド
|
US11117905B2
(en)
|
2016-12-14 |
2021-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as NRF2 activators
|
US20220002272A1
(en)
|
2016-12-14 |
2022-01-06 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl lactams as nrf2 activators
|
JP2020502152A
(ja)
|
2016-12-15 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしてのエーテル結合トリアゾール
|
BR112019012300A2
(pt)
|
2016-12-15 |
2019-11-12 |
Glaxosmithkline Ip Dev Ltd |
ativadores nrf2
|
EP3599899A1
(fr)
|
2017-03-23 |
2020-02-05 |
Virun, Inc. |
Poudres sèches et émulsions stables contenant des probiotiques et une protéine muco-adhésive
|
TWI778052B
(zh)
|
2017-04-24 |
2022-09-21 |
美商共結晶製藥公司 |
流感病毒複製之抑制劑
|
WO2019116231A1
(fr)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Activateur de nrf2 pour le traitement d'une lésion pulmonaire aiguë, d'un syndrome de détresse respiratoire aiguë et d'un syndrome de dysfonction d'organes multiples
|
JP2021505636A
(ja)
|
2017-12-11 |
2021-02-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
急性肺傷害、急性呼吸促迫症候群および多臓器不全症候群の処置のためのnrf2アクチベーター
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
CA3088347A1
(fr)
|
2018-01-17 |
2019-07-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhibiteurs de pi4kiiibeta
|
US20210228498A1
(en)
|
2018-02-08 |
2021-07-29 |
Neonc Technologies, Inc. |
Methods of permeabilizing the blood brain barrier
|
JP2021524469A
(ja)
|
2018-05-23 |
2021-09-13 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2アクチベーターとしてのインダン
|
KR20210038908A
(ko)
|
2018-07-27 |
2021-04-08 |
코크리스탈 파마, 아이엔씨. |
인플루엔자바이러스 복제 억제제로서의 피롤로[2,3-b]피리딘 유도체
|
US12037333B2
(en)
|
2018-09-10 |
2024-07-16 |
Cocrystal Pharma, Inc. |
Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication
|
CA3115823A1
(fr)
|
2018-10-17 |
2020-04-23 |
Cocrystal Pharma, Inc. |
Associations d'inhibiteurs de la replication du virus de la grippe
|
CA3119145A1
(fr)
|
2018-11-13 |
2020-05-22 |
Cocrystal Pharma, Inc. |
Formulations comprenant un acide 3-(2-(5-chloro-1h-pyrrolo[2,3-b]pyridine-3-yl)-5-fluoro-7h-pyrrolo[2,3-d]pyrimide-7-yl)bicyclo[2.2.2]octane-2-carboxylique pour le traitement de l'influenza
|
EP3887355A1
(fr)
|
2018-11-26 |
2021-10-06 |
Cocrystal Pharma, Inc. |
Inhibiteurs de la réplication du virus de la grippe
|
DE102020100550A1
(de)
*
|
2019-01-14 |
2020-07-16 |
Alfred Von Schuckmann |
Vorrichtung zum Inhalieren pulverförmiger Substanzen, Substanzbehälter für eine solche Vorrichtung sowie Verfahren zum Befüllen einer derartigen Vorrichtung
|
DE102019134285A1
(de)
|
2019-01-15 |
2020-07-16 |
Nuuvera Deutschland GmbH |
Vorrichtung und Verfahren zum Extrahieren und Aspirieren von Wirkstoffen, insbesondere aus der Cannabispflanze
|
KR20210141546A
(ko)
|
2019-03-14 |
2021-11-23 |
옴 파르마 에스아 |
안정한 박테리아 추출물 제조 공정 및 이의 약제로서의 용도
|
WO2020182322A1
(fr)
|
2019-03-14 |
2020-09-17 |
Om Pharma Sa |
Méthode de traitement et/ou de prévention de l'asthme, d'exacerbations de l'asthme, de l'asthme allergique et/ou d'états associés à un microbiote lié à des troubles respiratoires
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
USD943161S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer device
|
USD943159S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Component for a vaporizer cartridge
|
USD943160S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer device
|
USD943158S1
(en)
|
2019-11-14 |
2022-02-08 |
Juul Labs, Inc. |
Vaporizer cartridge
|
WO2021188620A1
(fr)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Dérivés de n5-méthyl-n2-(nonanoyl-l-leucyl)-l-glutaminate peptidomimétiques, dérivés de triazaspiro[4.14]nonadécane et composés similaires utilisés en tant qu'inhibiteurs de réplication de norovirus et de coronavirus
|
CN115698035A
(zh)
|
2020-04-10 |
2023-02-03 |
共晶制药公司 |
诺如病毒及冠状病毒复制的抑制剂
|
WO2021216547A1
(fr)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Administration pulmonaire de polypeptides ace2
|
WO2022175425A1
(fr)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhibiteurs de la kinase mtor inhalés destinés à être utilisés dans le traitement ou la prévention d'une infection par un virus respiratoire à arn
|
WO2022179967A1
(fr)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat pour le traitement de la covid-19 chez un sujet hospitalisé
|
JP2024521543A
(ja)
|
2021-04-14 |
2024-06-03 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
蒸発/凝縮による治療用エアロゾルの生成のための高温多孔体計量のシステムおよび方法
|
WO2022240897A1
(fr)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Composition pharmaceutique comprenant de la délafloxacine destinée à être administrée dans le poumon
|
WO2023014758A1
(fr)
|
2021-08-03 |
2023-02-09 |
Cocrystal Pharma, Inc. |
Inhibiteurs pour coronavirus
|
WO2023028364A1
(fr)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Compositions ciblées et leurs utilisations
|
WO2023205389A1
(fr)
|
2022-04-22 |
2023-10-26 |
Quench Medical Inc. |
Administration de produits pharmaceutiques par inhalation de poudre sèche
|
WO2023232976A1
(fr)
|
2022-06-03 |
2023-12-07 |
Ags Therapeutics Sas |
Vésicules extracellulaires provenant de microalgues génétiquement modifiées contenant une cargaison chargée de manière endogène, leur préparation et utilisations
|
WO2024095105A1
(fr)
*
|
2022-11-04 |
2024-05-10 |
Skietta Ag |
Vaporisateur pour la vaporisation d'un milieu d'inhalation
|